04:22 PM, 7th Mar 2025
We would like to inform the exchange that the USFDA has conducted an inspection at our Bioequivalence Facility located at Vadodara from 3rd March 2025 to 7th March 2025. The USFDA has issued a Form 483 with one procedural observation.